#AS­CO22: Rare bio­mark­er leads to ‘un­prece­dent­ed’ re­sults in small rec­tal can­cer study

In an on­go­ing, 18-per­son study, every sin­gle pa­tient that has com­plet­ed treat­ment saw their rec­tal can­cer com­plete­ly dis­ap­pear.

None of them need­ed chemother­a­py, ra­di­a­tion, or …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER